BioDuro Breaks Ground on 300,000 sq ft Facility in Jiangsu China
-- Site to host fully integrated drug discovery, development and manufacturing capabilities --
SAN DIEGO—On April 17, 2020, the groundbreaking ceremony for BioDuro’s China Innovative Drug R&D Center was held in Wuxi Huishan Life Science Park in Jiangsu, China. The site is BioDuro’s 4th global facility, and 3rd in China. Upon completion, the facility will add another 300,000 ft2 and 1,000 scientists to BioDuro’s contract research, development and manufacturing operations.
David Preston, Chairman of BioDuro, and TJ Deng, President of BioDuro gave speeches at the groundbreaking ceremony.
The BioDuro team were joined by government and industry leaders, including Wenbin Cao, a member of the standing committee of the Political Bureau of the CPC Central Committee. Mr. Cao highly affirmed BioDuro’s achievements and status in the field of new drug research and development CRO in his speech and expressed full confidence that the project will be completed promptly and put into operation as scheduled.
BioDuro reached agreement with Huishan Life Science and Technology Park in October 2019, following a comprehensive search, selecting the project site from more than 18 other cities. Shortly thereafter, the COVID-19 pandemic created global health and business challenges. Despite these challenges, BioDuro and the Wuxi government worked tireless at all levels to ensure the project started smoothly. The facility is set to begin operations in August 2020.
Additional video of the groundbreaking ceremony can be found at:
Additional Media coverage can be found at:
BioDuro, an Advent International portfolio company, is a leading global life sciences research and development organization that provides biopharmaceutical clients and partners with comprehensive, fully integrated drug discovery and development services, from lead development and IND-enabling studies to GMP manufacture of drug product for clinical trials. Core expertise includes small and large molecule discovery, development and scale up, combined with unique technology platforms such as bioavailability enhancement of insoluble compounds. The company has 4 global sites: headquarters in San Diego, California and 3 major operations in Beijing, Shanghai and Jiangsu, China. BioDuro’s integrated China and US teams afford partners with the benefits of a truly global and seamless operation, significantly accelerating discovery and de-risking development to create higher value outcomes.
For more information, visit: